EUVIMEDEUVIMED entdecken
Crossref

PYGO2 promotes resistance to chemotherapy via reducing apoptosis and G2/M cell cycle arrest in esophageal carcinoma cells

Fatemeh Ardalan Moghadam Al, Mohammad Mahdi Forghanifard, Vajiheh Zarrinpour

Medical Oncology · 2025

DOI: 10.1007/s12032-024-02590-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2025. Verfasst von Fatemeh Ardalan Moghadam Al und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Apoptosis, Drug Resistance, Neoplasm, Fluorouracil. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-FU is a widely used chemotherapy drug for esophageal carcinomas, but therapy failure has been observed in 5-FU-resistant patients. Overcoming this resistance is a significant challenge in cancer treatment, requiring identifying and targeting important resistance mechanisms. PYGO2 expression is crucial in developing resistance to various chemotherapy drugs. In this study, we aimed to investigate the impact of PYGO2 overexpression on the sensitivity of YM-1 and KYSE-30 esophageal carcinoma cells against 5-FU. To do this, we compared cell viability, cell cycle arrest, apoptosis rate, and mRNA expressions of various apoptosis-related genes between pcDNA3-PYGO2 transfected and untransfected KYSE-30 and YM-1 esophageal carcinoma cells following treatment with 5-FU. We showed that PYGO2 expression reduces 5-FU sensitivity in YM-1 and KYSE-30 cells. PYGO2-overexpressing cells treated with 5-FU have exhibited a noteworthy reduction in both early and late apoptotic cells compared to controls. Furthermore, a significant decrease in the Bax/Bcl2 ratio and P53 gene expression was observed. 5-FU induces G2/M cell cycle arrest in YM-1 and KYSE-30 cells. However, PYGO2 overexpression impeded G2/M cell cycle arrest in 5-FU-treated cells, thereby suppressing the toxicity of 5-FU. PYGO2 may mediate its apoptotic effect by regulating cell cycle regulatory proteins, specifically cyclin D1 and p21. These results highlight PYGO2's capacity to alter how esophageal cancer cells respond to 5-FU therapy, emphasizing its importance as a potential focal point for treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsApoptosisDrug Resistance, NeoplasmFluorouracilG2 Phase Cell Cycle CheckpointsIntracellular Signaling Peptides and ProteinsHumansCell Line, Tumor

Stichwörter der Autor:innen

5-FUApoptosisEsophageal carcinomaPYGO2 protein

Substanzen

FluorouracilIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran.
  • Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran. MM.Forghanifard@iau.ac.ir.

Zitieren

APA

Ardalan Moghadam Al, F., Forghanifard, M. M., & Zarrinpour, V. (2025). PYGO2 promotes resistance to chemotherapy via reducing apoptosis and G2/M cell cycle arrest in esophageal carcinoma cells. Medical Oncology. https://doi.org/10.1007/s12032-024-02590-4

Vancouver

Ardalan Moghadam Al F, Forghanifard MM, Zarrinpour V. PYGO2 promotes resistance to chemotherapy via reducing apoptosis and G2/M cell cycle arrest in esophageal carcinoma cells. Medical Oncology. 2025. doi:10.1007/s12032-024-02590-4

BibTeX
@article{ArdalanMoghadamAl2025,
  author = {Ardalan Moghadam Al, Fatemeh and Forghanifard, Mohammad Mahdi and Zarrinpour, Vajiheh},
  title = {PYGO2 promotes resistance to chemotherapy via reducing apoptosis and G2/M cell cycle arrest in esophageal carcinoma cells},
  journal = {Medical Oncology},
  year = {2025},
  doi = {10.1007/s12032-024-02590-4}
}
Kostenlos starten →